Your browser doesn't support javascript.
loading
Comparison of Bivalent and Monovalent mRNA Vaccine Boosters.
Wong, Carlos K H; Lau, Kristy T K; Au, Ivan C H; Lau, Eric H Y; Cowling, Benjamin J.
Afiliação
  • Wong CKH; Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region (SAR), China.
  • Lau KTK; Laboratory of Data Discovery for Health (D24H), Hong Kong Special Administrative Region (SAR), China.
  • Au ICH; Department of Family Medicine and Primary Care, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region (SAR), China.
  • Lau EHY; The Vaccine Confidence Project, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Cowling BJ; Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region (SAR), China.
Clin Infect Dis ; 78(3): 633-636, 2024 03 20.
Article em En | MEDLINE | ID: mdl-37647855
ABSTRACT
In this cohort study conducted in Hong Kong where both bivalent and monovalent formulations of BNT162b2 were available, there were no significant differences in the mortality or hospitalization between those who received bivalent and monovalent mRNA as second boosters. Bivalent and monovalent mRNA boosters appear equally protective against clinical outcomes.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas de mRNA / Vacina BNT162 Tipo de estudo: Observational_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Clin Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas de mRNA / Vacina BNT162 Tipo de estudo: Observational_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Clin Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China